UK MHRA Guidance: Clinical Trials for Medicines: Roles and Responsibilities

Sharan Murugan
2 hours ago
3 min read

The guidance Clinical trials for medicines: Roles and responsibilities provides a comprehensive framework that outlines how responsibilities are distributed among stakeholders involved in clinical trials in the United Kingdom.

Introduction

Clinical trials in the UK are governed by a structured system where responsibilities are clearly defined to ensure participant safety, ethical conduct, and reliable data generation. This guidance outlines the roles of key stakeholders, including sponsors, investigators, regulators, and ethics committees, across the clinical trial lifecycle.

Background

Clinical trials involving investigational medicinal products (CTIMPs) require oversight by the Medicines and Healthcare products Regulatory Agency, which is responsible for authorisation, monitoring, and inspection of trials in the UK.

In addition to regulatory approval, trials must also receive a favourable opinion from research ethics committees coordinated by the Health Research Authority (HRA). This dual oversight ensures that trials meet both scientific and ethical standards, forming the foundation of UK clinical research governance.

Scope

This guidance applies to all stakeholders involved in clinical trials for medicines in the UK, including:

Sponsors
Investigators and trial sites
Contract research organisations (CROs)
Regulatory authorities and ethics committees

It covers responsibilities across the full trial lifecycle, from design and approval to conduct, monitoring, and reporting.

Role of the Sponsor

The sponsor holds overall responsibility for the clinical trial and must ensure that it is conducted in compliance with legislation and Good Clinical Practice (GCP). The sponsor is accountable for:

Trial design and protocol development
Submission for regulatory and ethical approval
Ensuring adequate financing and insurance
Oversight of trial conduct and data quality

Even when responsibilities are delegated to third parties such as CROs, the sponsor retains ultimate accountability for the trial.

Role of the Investigator

The investigator is responsible for the day-to-day conduct of the trial at the site level, ensuring that the study is carried out according to the approved protocol and ethical standards.

Investigators must ensure participant safety, obtain informed consent, and maintain accurate records of trial data. They also play a critical role in reporting adverse events and ensuring compliance with regulatory requirements.

Role of the MHRA

The Medicines and Healthcare products Regulatory Agency acts as the national regulatory authority responsible for:

Authorising clinical trials before they begin
Monitoring compliance with regulations
Conducting inspections
Taking enforcement actions where necessary

The MHRA ensures that clinical trials meet standards of safety, quality, and efficacy, protecting public health throughout the research process.

Role of Ethics Committees

Research Ethics Committees (RECs), coordinated by the Health Research Authority, are responsible for reviewing the ethical aspects of clinical trials.

They assess whether the rights, safety, dignity, and well-being of participants are adequately protected. A favourable ethical opinion is required before a trial can proceed.

Delegation and Oversight

While responsibilities can be delegated to third parties such as CROs, the guidance emphasizes that accountability cannot be transferred.

Sponsors must ensure that delegated parties are qualified and that appropriate oversight mechanisms are in place. This includes monitoring performance, ensuring compliance, and maintaining documentation of all delegated activities.

Communication and Reporting

Effective communication between stakeholders is essential for the successful conduct of clinical trials.

Sponsors and investigators must ensure timely reporting of:

Adverse events and safety issues
Protocol deviations
Trial progress updates

Regulatory authorities and ethics committees rely on this information to maintain oversight and ensure participant safety.

The guidance reinforces that clearly defined roles and responsibilities are essential for conducting safe, ethical, and reliable clinical trials. By ensuring accountability at every level—from sponsors to investigators—the UK regulatory framework supports high-quality research and protects participants.